Brown Adrienne S 4

What Happened

• Adrienne S. Brown, EVP and President of LLY Immunology at Eli Lilly, received an award (transaction code A) of 1,196.308 shares on 2026-02-09.
• The reporting price listed is $1,044.67 per share, for a total grant value of approximately $1,249,747. This was a compensation award/grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-09; Report filed on Form 4: 2026-02-11 (timely within reporting window).
• Price per share: $1,044.67; Total value: ~$1,249,747.
• Shares acquired: 1,196.308 (award/grant; Form 4 reports an acquisition).
• Shares owned following the transaction: not specified in the provided filing summary.
• Transaction code: A = Award/Grant. No 10b5-1, tax-withholding, or other footnotes were provided in the summary.

Context

• Awards like this are typically part of executive compensation (e.g., restricted stock, RSUs, or performance shares) and reflect compensation decisions rather than direct market buying or selling.
• Such grants can vest over time or be subject to performance conditions; they are informative about pay but are not the same signal as an open-market purchase by an insider.